2022
DOI: 10.1016/j.mib.2022.102191
|View full text |Cite
|
Sign up to set email alerts
|

Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 65 publications
0
11
0
Order By: Relevance
“…It is commonly accepted that one of the key causes for this resiliency is the Mycobacterium tuberculosis cell envelope [ 6 , 7 ]. Atypical among bacteria, it has an elaborate dense multilayered structure, devoid of the majority of transporters, that helps to protect it against the actions of the host immune cells, adverse environments, and many antimicrobial agents.…”
Section: Introductionmentioning
confidence: 99%
“…It is commonly accepted that one of the key causes for this resiliency is the Mycobacterium tuberculosis cell envelope [ 6 , 7 ]. Atypical among bacteria, it has an elaborate dense multilayered structure, devoid of the majority of transporters, that helps to protect it against the actions of the host immune cells, adverse environments, and many antimicrobial agents.…”
Section: Introductionmentioning
confidence: 99%
“…Nevertheless, the anti-tubercular drug discovery and development projects face many complications that result in high attrition rates, leaving clinical needs unmet [ 47 , 48 , 49 ]. In particular, the target-based approaches using biochemical screening assays and/or in silico models [ 50 ] to identify and optimize inhibitors have so far failed to produce any clinical drug candidates, primarily due to their lack of whole-cell activity [ 30 , 48 ].…”
Section: Introductionmentioning
confidence: 99%
“…In particular, the target-based approaches using biochemical screening assays and/or in silico models [ 50 ] to identify and optimize inhibitors have so far failed to produce any clinical drug candidates, primarily due to their lack of whole-cell activity [ 30 , 48 ]. It is commonly accepted that one of the key causes for this is the extremely low permeability of the mycobacterial cell envelope [ 49 ]. Atypical among bacteria, the M. tuberculosis cell envelope has an elaborate dense multilayered structure devoid of the majority of transporters, with the wax-like outer membrane formed by mycolic acids and their derivatives [ 12 , 49 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations